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Introduction. The best pancreatic anastomosis technique after pancreaticoduodenectomy (PD) is still debated. Pancreatic ﬁstula
(PF) is the most important complication but is also related to postoperative bleedings and pancreatic remnant involution. We
support pancreaticojejuno anastomosis (PJ) advantages describing our technique with brief technical considerations. Materials
and Methods. 89 consecutive patients underwent PD with suprapyloric gastric resection and double loop reconstruction.
Pancreaticojejunal end-to-end anastomosis was done by simple invagination with a single layer of interrupted pledget-supported
Ticronstitches. Results.Pancreaticﬁstulaoccurredinsevenpatients(7.8%):sixcasesofgradeAﬁstularesolvedspontaneously,and
in only one case of grade B ﬁstula percutaneous drainage was necessary. Postoperative hemorrhage occurred in only two (2.2%) of
89 patients. Conclusion. Pancreaticojejunostomy with minor changes in anastomotic techniques can contribute to improvement of
the outcome of Roux-en-Y reconstruction regarding PF and other related complications. The particular reconstruction reported
seems also to preserve the pancreatic exocrine function.
1.Introduction
Thebestpancreaticanastomosistechniqueafterpancreatico-
duodenectomyisstilldebated[1,2].Pancreaticojejunostomy
is the commonly preferred method of anastomosis but
the incidence of pancreatic ﬁstula does not seem diﬀer-
ent according to the many techniques proposed for the
reconstruction of pancreatic digestive continuity [3]. Other
complications are also related to the onset of pancreatic
ﬁstula. The postoperative bleeding due to the erosion of
peripancreatic vessels by the extravasated pancreatic juice
has been described in 2–8% of cases [4–6] but morbidity
rate increases from 6% to 26% when pancreatic ﬁstula
becomemanifest[7–9].Finally,someauthorsbelievethatthe
involution of the residual pancreatic remnant is also related
to the onset of the pancreatic anastomosis leakage [10].
The authors report their experience with a particu-
lar PJ technique, evaluating the results on postoperative
complications in a personal reconstruction modality after
pancreaticoduodenectomy and making some pathophysio-
logical considerations to support the advantages of PJ.
2.MaterialsandMethods
We considered 89 consecutive patients who underwent PD
at “La Sapienza” University (Rome, Italy) from January
1995 to June 2011. The mean age of patients was 60.8
years (range 35–85) (65.2% were males and 34.8% females).
The underlying diseases were pancreatic carcinoma in 54
cases; pancreatic serous cystadenoma in six cases; mucinous
cystadenoma in one case; pancreatic endocrine tumor in
two cases; ampullar carcinoma in ten cases; distal bile duct
carcinomain twelvecases;chronicpancreatitis in threecases;
a non-Hodgkin lymphoma of the pancreatic head in 1 case.
In all patients, the surgical procedure comprised PD with
suprapyloric gastric resection and Roux-en-Y reconstruction2 International Journal of Surgical Oncology
Pledget
Splenic
artery
Portal vein Wirsung
catheter
Jejunal loop
Jejunal 
loop
Pancreas
Pancreas
Collagen patch
Figure 1: Roux-en-Y pancreaticojejuno anastomosis: pledgetsup-
ported Ticron stitches between the seromuscularis of the jejunum
and the pancreatic capsule, before the pancreatic invagination. A
small catheter is inserted in the main pancreatic duct. On the
right side, anterior aspect of pancreaticojejunal anastomosis after
application of TachoSil.
with anastomosis of the isolated Roux limb to the stomach
and single Roux limb to both the pancreatic stump and
hepatic duct. A meticulous hemostasis performed using
bipolar coagulation and prolene 5/0 was carried out on the
pancreatic section surface. In all patients the consistency of
the pancreatic gland was noted as being soft or hard. Small
catheter was inserted in the main duct, passed through the
anastomosed bowel loop, and ﬁxed to the abdominal wall
(Figure 1). Wirsung duct size was evaluated according to the
caliber of the catheter used for cannulation, considering it as
normal when using a catheter No. 6 French and dilated when
it was No. 8 French. A drainage tube was placed near the
pancreaticojejunostomy; external biliary drainage was not
used. Pancreaticojejuno end-to-end anastomosis was done
by simple invagination of the pancreatic stump into the jeju-
nal loop for 2cm and suturing all around with a single layer
ofinterruptedpledget-supportedTicronstitchesbetweenthe
seromuscularis of the jejunum and the pancreatic capsule
(Figure 1). This establishes a close contact between the
jejunal loop serosa and the pancreatic capsule. From January
2005,ﬁbrinogen-/thrombin-coatedcollagenpatch(TachoSil,
Nycomed, UK Ltd.) has been also layered on suture line
of pancreaticojejuno anastomosis (Figure 1) in the last 35
patients. All patients in our study received octreotide during
the ﬁrst six postoperative days. The postoperative surgical
outcome within 60 postoperative days was assessed. PF,
postoperative hemorrhage, and delayed gastric emptying
(DGE) were assessed according to the International Study
Group of Pancreatic Fistula and International Study Group
of Pancreatic Surgery deﬁnitions [11]. 6 months postopera-
tively a group of 10 patients was subjected to assessment of
pancreatic exocrine function reserve by evaluation of fecal
elastase-1 concentration and by dynamic MR study of the
pancreatic stump, with simultaneous stimulation with I.V.
secretin injection (1U/kg).
3. Results
The consistency of the pancreas was considered soft in 54
cases and hard in 35.
ANo.6Wirsungcatheterwasusedin29casesandaNo.8
catheter in 60, corresponding to a normal or dilated Wirsung
duct caliber.
PF occurred in seven patients (7.8%): six cases of grade
A ﬁstula resolved spontaneously, and in only one case of
grade B ﬁstula percutaneous drainage was necessary. In the
6 patients with a grade A pancreatic ﬁstula, the pancreas was
soft in 4 cases and hard in 2. In the single patient with grade
B pancreatic ﬁstula, the pancreatic consistency was soft.
Regarding the size of the Wirsung catheter, the caliber
was No. 6 in all patients who developed a pancreatic ﬁstula.
Mean age of patients with pancreatic ﬁstula was 60.5 years.
Postoperative hemorrhage occurred in only two (2.2%)
of 89 patients, biliary ﬁstula in eight cases (8.9%), acute
pancreatitis in one case (1.1%), and one patient with
preexisting stenosis of hepatic artery developed thrombosis
of the hepatic artery.
Grade A DGE occurred in eight patients (8.9%), grade C
DGE in one patient (1.1%), left pleural eﬀusion in 15 cases
(16.8%), and wound infection in eight cases (8.9%).
Postoperative mortality rate was 2.2% (two out of 89
patients: acute myocardial infarction; sepsis due to acute
pancreatitis).
Regarding the assessment of exocrine functional reserve
of the pancreatic stump, in the 10 patients evaluated for
pancreatic fecal elastase-1 and dynamic MR pancreatograms
with secretin stimulation, only 2 cases showed fecal elastase-
1 below 200 (normal range: 200–500 micrograms/g of feces)
with a lack of dilation of the residual Wirsung duct and
poor ﬁlling of the anastomosed pancreatic jejunal loop,
documented by dynamic MR after secretin stimulation.
The remaining 8 patients, on the other hand, showed
an increase of Wirsung duct caliber with normal passage
of pancreatic juice in the anastomosed jejunal loop after
secretin stimulation and fecal elastase-1 concentration in the
normal range.
4. Discussion
A recent meta-analysis [12] shows no statistically signiﬁcant
diﬀerences among diﬀerent pancreatic reconstructions after
PD.
Although a meta-analysis possibly provides the best
methodology, it is usually limited by clinical heterogeneity.
The lack of a uniform deﬁnition of PF and postoperative
complications hampered the data analysis and resulted in
clinical heterogeneity. The modiﬁed technique of pancreatic
reconstruction after PD may also result in clinical hetero-
geneity. For example, PJ is performed as either an end-to-
end anastomosis with invagination of the pancreatic stump
into the jejunum or as an end-to-side anastomosis. A main
pancreatic duct stent might be placed across these anasto-
moses.Thus,theoverallheterogeneityoftheavailablestudies
severely hampers conclusive comparisons, and therefore one
must make interpretations with caution.
We believe with others that the successful management
of pancreatic anastomoses may depend more on meticulous
surgical techniques, surgical volume, and other managementInternational Journal of Surgical Oncology 3
parameters rather than on the type of technique used
[12]. But we also think that few considerations are very
important about the choice of reconstructive procedure on
postoperative complications and also on functional outcome
of the pancreatic remnant after PD.
The invagination of pancreatic stump into the jejunal
loop and the sealing eﬀects of TachoSil layered on a pancre-
aticojejunal anastomosis may reduce the risk of the overﬂow
of pancreatic juice from the anastomosis site during the ﬁrst
postoperativedaysandmayminimizetheriskofhemorrhage
due to vessel erosion or development and bleeding of visceral
arterial pseudoaneurysms caused by digestion of the arterial
vessel wall near a pancreaticojejunal leak by trypsin and
elastase [4–6]. The pancreatic juice that escapes from the
lower ducts on pancreatic section line must be considered,
and therefore we believe that the invagination of pancreatic
stump can allow a physiological collection of the pancreatic
juice into the jejunal loop, limiting its extravasation.
Carrying out PJ by invagination of the pancreatic stump
into the jejunum and Ticron-pledgeted sutures makes a
homogeneous anastomotic surface that supports the adhe-
sion of TachoSil and optimizes the sealing eﬀect. Pledgeted
sutures make easy the pancreatic invagination even in cases
of soft pancreatic parenchyma.
Similarly, we believe that it is useful to place a drain into
the Wirsung duct in the ﬁrst days after surgery because it
brings out a large amount of the pancreatic juice. In case
of anastomotic leakage the pancreatic juice that comes in
contactwiththedehiscentareaisminimized.Thishypothesis
has been recently supported by others [13].
Regarding the pancreaticogastrostomy, more intralumi-
nal postoperative hemorrhages and more severe exocrine
insuﬃc i e n c yt h a nP Jh a v eb e e nr e p o r t e di nd i ﬀerent studies
with signiﬁcantly more severe atrophic changes in remnant
pancreas [14]. Obstruction or stenosis of the pancreati-
codigestive anastomosis has been suggested to be the cause
of ductal dilatation and parenchymal atrophy after pan-
creaticoduodenectomy [15–17], and, as Tajima underlines,
anastomotic stenosis may occur after pancreatic anastomosis
leakage [10].
From this point of view and according to our experience,
if the PJ shows a low incidence of PF often of grade A with
a low incidence of hemorrhagic complications related to PF,
we believe that PJ should be considered as an advantageous
surgical choice.
The impact of reconstruction procedure other than
the type of pancreaticoenteric anastomosis should also be
considered in the evaluation of morphologic and functional
changes of the remnant pancreas after pancreaticoduodenec-
tomy.
Apart from anastomotic stenosis, involutional atrophy
of the pancreatic remnant may also be a consequence
of deregulation of pancreatic neurohormonal stimulatory
factors resulting from pancreaticoduodenectomy [16, 18,
19].
Mori and colleagues demonstrated that pancreatic dys-
function was due not only to gastrectomy and duodenec-
tomy resulting from pancreaticoduodenectomy, but was also
related to treatment of the pancreatic remnant [20].
The pancreatic remnant may then be able to preserve its
exocrine and endocrine function if its physiologic stimuli are
maintained.
According to our previous works [21], we believe that
two conditions are very important in the maintenance
of pancreatic exocrine function after pancreaticoduodenec-
tomy. First, gastric preservation favours adequate weight
gain after surgery due to higher caloric intake. Normal acid
secretion acts as a physiologic stimulus on the duodenal
mucosa, promoting the secretion of secretin and CCK-PZ
[22], as well as the subsequent stimulation of pancreatic
exocrine secretion with better digestion of protein and fat
(weight gain). Second, after removal of the duodenal source
of CCK and secretin, preservation of the ﬁrst jejunal loop
in the reconstruction of the alimentary circuit maintains
the physiologic jejunal secretion of secretin and CCK-PZ
subsequent to alimentary transit and can compensate (at
least in part) for the abolished duodenal hormonal release.
Because of the elimination of the entire duodenum,
basal concentrations of plasma CCK are signiﬁcantly lower
in patients who undergo pancreatoduodenectomy than in
preoperative patients, and postprandial plasma secretin con-
centrations are signiﬁcantly lower in patients who undergo
the Whipple procedure than in control patients or patients
treated by pylorus-preserving pancreaticoduodenectomy in
which the entire stomach and duodenal bulb are preserved.
Moreover, reduced (but signiﬁcant) amounts of CCK and
secretin are released postprandially even after pancreatico-
duodenectomy, suggesting a compensatory mechanism of
the remnant of the upper small intestine: in fact, after the
duodenum, the upper jejunum is the second most important
source of release of CCK and secretin [23, 24].
In our technique of pancreaticoduodenectomy, we
adopted a suprapyloric gastric resection (i.e., subtotal
stomach preserving) and Roux-en-Y reconstruction with
anastomosis of the isolated Roux limb (i.e., ﬁrst jejunal
loop) to the stomach and single Roux limb (i.e., second
jejunal loop) to the pancreatic stump and hepatic duct [25].
According to these assumptions, we observed, by dynamic
MR pancreatograms obtained by secretin injection, that the
patency of the pancreaticojejunal anastomosis was evident in
all patients evaluated [21]. In the same group, the concen-
tration of fecal-1 elastase decreased only in the two patients
with reduced jejunal ﬁlling detected by dynamic MR [21].
5. Conclusion
Pancreaticojejunostomy with minor changes in anastomotic
techniques can contribute to improvement of the outcome
of Roux-en-Y reconstruction regarding PF and other related
complications. The particular reconstruction reported seems
also to preserve the pancreatic exocrine function as detected
by MR pancreatography with secretin stimulation and fecal
1-elastase assay.
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